Potent, selective CK1δ inhibitor (IC 50 values are 0.29, 1.3 and 2.5 μM for CK1δ, ε and α, respectively). Induces period lengthening of the circadian rhythm in U2OS cells.LH846 is a potent and selective inhibitor of the known clock regulatory kinase Casein Kinase CK1δ, with an IC50 of 290 nm, compared to an IC50 of 2.5 μm for CKIα , 1.3 μm for CKIε, and minimal effect on CK2 and 50 other kinases tested. Circadian rhythym has been studied for a long time for things such as jet lag rhythym related disorders, but more recently it has beencome apparent that clock dysfunction can contribute to a variety of pathologies including circadian sleep disorders, cardiovascular disease, cancer, and metabolic disease, so studies of clock regulating enzymes have increased. LH846 increased circadian period by 10 hours in human U2OS cells.
Storage
Protected from light,Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Aktionsart
INHIBITOR
Hinweis
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
This compound belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids.
External Descriptors
Not available
1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Bewertungen
Kundenbewertungen
Application Protocols
No tested application protocols are provided in the Product Data for this item. The following generic procedures are commonly used for small-molecule tool compounds and should be adapted to your assay system.
General compound handling for cell-based assays:
Stock preparation: Dissolve LH846 in anhydrous DMSO to 10–50 mM. Filter through a 0.22 µm PTFE filter if particulate remains and the compound is stable.
Working dilutions: Prepare serial dilutions in DMSO (e.g., 3-fold or 10-fold) and add to media to achieve the desired final concentrations, keeping final DMSO constant across wells (≤0.5–1% v/v typical).
Dose–response: 8–12 concentrations spanning at least two logs; include vehicle controls and, if available, a positive control relevant to the pathway/target under study.
Readouts: Choose endpoint appropriate to hypothesis (e.g., luciferase reporter, Western blot for pathway markers, qPCR, viability assays). Include counterscreens to detect assay interference and nonspecific effects.
Biochemical/enzymatic assays (if applicable):
Determine Km(ATP) for the enzyme of interest; run IC50 determinations at multiple ATP concentrations to infer mechanism (competitive vs noncompetitive).
Include detergent (e.g., 0.01% Triton X-100 or Tween 20) to mitigate aggregation artifacts, if compatible.
Note: Optimize parameters empirically; these are general recommendations, not product specifications.
Biological Roles
Item-specific biological role claims are not provided in the Product Data. The points below summarize general considerations for small-molecule tool compounds, with literature context where applicable.
General considerations:
Tool compounds are used to perturb cellular pathways, enabling hypothesis testing about signaling, transcriptional regulation, or enzymatic cascades. Interpretation requires target verification, selectivity profiling, and orthogonal assays.
Literature context for LH846 (to be independently verified):
LH846 has been described in the literature as a small-molecule modulator of Wnt/β-catenin signaling, reportedly via interaction with casein kinase 1 (CK1) isoforms in certain systems. If pursued as a pathway probe, confirm mechanism by direct biochemical assays (e.g., CK1 enzymology), target occupancy/proximity assays, and downstream pathway readouts (Axin stabilization, β-catenin levels, reporter assays like TOPFlash).
Experimental cautions:
Off-target activities are common; perform broad counterscreens (kinase panels or cellular profiling) where possible.
Solvent carrier (DMSO) can impact membrane integrity and enzyme kinetics at higher percentages; keep constant across controls and treatments.
For live-cell assays, consider efflux/uptake transporter interactions and serum binding that may limit free concentration; adjust dosing accordingly.
Research-use-only statement:
This material is supplied strictly for research use. No clinical, diagnostic, or in vivo therapeutic applications are supported or implied.
Buffer Applications
This product is a small organic compound rather than a buffering reagent. It is not typically used to establish or maintain pH.
Practical guidance (if used in aqueous buffers for assays):
Prepare a concentrated DMSO stock and dilute into the target buffer (e.g., PBS, HEPES, Tris) with rapid mixing to minimize precipitation. Maintain a consistent final DMSO percentage across all wells/tubes.
Where precipitation is observed upon dilution, consider adding a minimal amount of co-solvent (e.g., 0.1–1% DMSO in the final buffer), gentle heating to 37°C during dilution, or using a small amount of non-ionic surfactant if compatible with the assay.
Buffer systems (examples for assay context; not specific to LH846):
HEPES (pKa ~7.5, effective pH 6.8–8.2) and MOPS (pKa ~7.2) are common in cell-based and biochemical assays due to minimal metal binding and temperature coefficients compared with Tris.
For pH-critical work, choose buffers based on enzyme/pathway requirements; LH846 itself does not confer buffering capacity.
Green Alternatives
As LH846 is a research-only small molecule rather than a bulk solvent or reagent, “green alternatives” focus on greener handling and solvent choices during dissolution, purification, and assay preparation.
Greener solvent considerations (general):
Prefer DMSO for stock solutions over DMF or NMP due to lower toxicity and better biodegradability profile; maintain low final assay concentrations to mitigate biological interference.
For purification or analytical work, consider ethanol or isopropanol as eluents/modifiers where compatible, in place of acetonitrile or dichloromethane. For normal-phase work, cyclopentyl methyl ether (CPME) or 2-MeTHF can sometimes substitute for ethers or chlorinated solvents.
Comparison (general, context-dependent):
DMSO vs DMF/NMP: lower reproductive toxicity concerns for DMSO; DMF/NMP are more problematic under regulatory frameworks.
2-MeTHF/CPME vs THF/Et2O: reduced peroxide formation tendency and improved safety; water content and azeotrope behavior differ.
Operational practices to lower environmental impact:
Minimize organic solvent volumes by adopting microscale assays and 96/384-well formats.
Use closed, low-evaporation reservoirs to reduce VOC emissions.
Implement solvent recycling where appropriate (e.g., rotovap collection for ACN/MeOH from prep HPLC), and segregate halogenated from non-halogenated waste to enhance recycling routes.
Note: Selection must be balanced against compound solubility and assay requirements; verify compound stability and performance in any substituted solvent system.
Pharmaceutical Uses
No pharmacopeial status, excipient role, or manufacturing use is provided for this research compound. This product is supplied strictly for research use only and is not intended for human or veterinary use.
Context (general for tool compounds):
In preclinical research, small molecules may be used to interrogate targets/pathways during hit validation and lead optimization. However, without established quality attributes (ICH/Q3 limits, residual solvents, elemental impurities) and without GMP manufacturing, such materials are not suitable for clinical or manufacturing use.
Formulation considerations for research models (in vitro/in vivo screening, general):
In vitro: DMSO stock solutions diluted into assay media, keeping final DMSO ≤0.5–1% v/v.
Ex vivo or exploratory in vivo models (if permitted by your institution and regulations): develop vehicle systems such as PEG400/saline, Captisol, or lipid-based formulations. Verify stability and do not extrapolate to clinical contexts.
Regulatory note:
No USP/EP/JP monograph is implied. For any work beyond basic research, source GMP-grade material with full regulatory documentation.
Physical Properties
Item-specific physicochemical data were not provided in the Product Data.
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Melting point (MP): Not specified for this item; refer to CoA/Spec Sheet.
Boiling point (BP): Not specified for this item; refer to CoA/Spec Sheet.
Density: Not specified for this item; refer to CoA/Spec Sheet.
Solubility: Not specified for this item; refer to CoA/Spec Sheet. (General practice for screening molecules: initial dissolution in anhydrous DMSO, then dilution into aqueous assay buffers with attention to final DMSO %.)
logP/logD, pKa, refractive index: Not specified for this item; refer to CoA/Spec Sheet.
Literature/cheminformatics note (general):
For small-molecule library members, key computed properties (cLogP, TPSA, HBD/HBA, rotatable bonds) are often used to anticipate permeability and solubility. If structure is confirmed (e.g., via PubChem CID 851474), these parameters can be computed using standard tools (ACD/Percepta, RDKit, ChemAxon). Ensure alignment with batch identity documents before relying on such values.
Practical guidance:
If crystallinity and MP are unknown, perform a micro-scale differential scanning or a melting-point capillary test to inform handling.
Conduct a small solubility screening (DMSO, DMF, MeOH, acetonitrile, PBS with surfactant) at analytical scale to determine suitable stock solvent and working concentrations for assays.
Quality and Grades
Grade/purity for this specific item: Not specified for this item; refer to CoA/Spec Sheet.
Interpreting grade (general guidance for small-molecule screening compounds):
Screening/library grade typically emphasizes identity confirmation (e.g., NMR/LC–MS), purity adequate for biochemical or cell-based assays (commonly ≥90% by HPLC unless otherwise indicated), and controlled storage. Exact acceptance criteria are batch-specific; consult the CoA for: HPLC purity, residual solvent profile, water content (KF), and analytical identity results.
Stabilizers: Not specified for this item; refer to CoA/Spec Sheet. If stabilizers are present, they will be listed in the CoA; be aware of potential interference in UV-based assays.
What to check on receipt:
Confirm catalog ID (L304252), CAS (639052-78-1), and batch/lot. Review CoA for purity, identity (LC–MS m/z, 1H NMR), and any noted polymorphism or solvate/hydrate state.
Verify storage instructions: protected from light, −20°C. If the container warms during transit, inspect for degradation via quick LC–UV; compare to CoA trace.
Analytical notes:
For quantitative biology assays, it is good practice to verify purity by orthogonal methods (HPLC–UV and LC–MS). If your assay is highly sensitive, consider additional purification or prepare fresh stocks immediately before use.
Reaction and Applications
Manufacturer application details were not provided. The following guidance reflects common uses of bioactive small molecules in research.
Research applications (general):
Chemical biology: use as a tool compound in target/pathway interrogation, phenotypic screening, and SAR follow-up. Validate identity and purity prior to quantitative experiments.
Assay development: dose–response curves (8–12 points) to estimate potency; include DMSO vehicle controls and counter-screens for assay interference (aggregation, redox cycling, pan-assay interference chemistry if suspected by structure).
Literature note specific to LH846 (general, verify with primary sources):
LH846 has been reported in the literature as a modulator of the Wnt/β-catenin pathway via casein kinase 1 (CK1) inhibition in certain assay contexts. If using for pathway studies, confirm target engagement in your system (e.g., reporter assays, biochemical kinase assays) and verify batch identity.
Practical tips:
Prepare concentrated DMSO stocks (e.g., 10–50 mM) and store as aliquots at −20°C, protected from light.
For cell-based assays, test multiple timepoints and include cytotoxicity counterscreens (e.g., resazurin, CellTiter-Glo) to decouple on-target effects from viability changes.
If photolability is suspected (light-protected storage is specified), minimize light exposure during handling (amber vials, foil-wrapped plates) and evaluate stability by LC–UV before lengthy incubations.
Reaction Conditions
As sold, LH846 is intended for use as a research tool compound, not as a reagent in synthetic transformations. Accordingly, there are no item-specific reaction conditions.
General considerations (if preparing stocks or handling during assays):
Dissolution: Prepare in anhydrous DMSO at room temperature. If dissolution is slow, gentle warming (≤40°C) and vortexing/sonication can help. Avoid prolonged heating or bright light exposure, per storage guidance.
Dilution into aqueous media: Add DMSO stock to vigorously stirred or vortexed buffer/media to minimize local supersaturation. Typical final DMSO ≤0.5–1% v/v.
If undertaking synthetic modification (after confirming structure):
Typical coupling conditions (general literature guidance):
Amide formation: HATU or EDC·HCl/HOBt in DMF or DCM; base such as DIPEA; 0–25°C, 1–12 h.
Suzuki–Miyaura: Pd(PPh3)4 or Pd-precatalyst, K2CO3/K3PO4 base, dioxane/H2O or toluene/EtOH/H2O, 60–100°C, 2–16 h.
Buchwald–Hartwig amination: Pd2(dba)3 with BINAP/XPhos, NaOtBu or Cs2CO3, toluene/dioxane, 80–110°C, 4–24 h.
Always verify compatibility with the functional groups present in LH846’s scaffold before applying conditions; monitor by LC–MS and quench appropriately.
Note: The above are generalized literature conditions and not specifications for this product.
Safety and Handling
Safety information specific to this item is not fully provided in the Product Data. Always consult the product SDS for authoritative guidance.
Signal word: Not specified for this item; refer to SDS.
GHS classification / pictograms: Not specified for this item; refer to SDS.
Hazard statements (H-codes): Not specified for this item; refer to SDS.
General laboratory precautions for small organic research compounds:
Personal protective equipment: lab coat, safety glasses or splash goggles, and appropriate chemically resistant gloves (e.g., nitrile). Handle within a fume hood to avoid inhalation of dust or vapors.
Avoid ingestion, inhalation, and skin/eye contact. Wash thoroughly after handling. Do not pipette by mouth.
Storage incompatibilities: segregate from strong oxidizers and strong acids/bases unless compatibility is known. Protect from light as specified; store at −20°C in a tightly closed, inert-container. Minimize freeze–thaw by preparing single-use aliquots.
Spill/first aid (overview; defer to SDS): contain small spills with inert absorbent; avoid raising dust. For skin contact, wash with soap and water; for eye contact, rinse with water for at least 15 minutes and seek medical attention. If inhaled, move to fresh air.
Waste: dispose in accordance with institutional and local regulations for organic chemical waste; do not discharge to drains.
Shipping/handling notes:
Shipped on ice packs in an insulated container to limit thermal and light exposure. Allow to equilibrate briefly at room temperature in the dark before opening to prevent condensation.
Solvent Selection
Item-specific solubility data are not provided. The guidance below reflects common practices for small-molecule library members.
Primary stock solvent (typical): DMSO (anhydrous) due to broad solubilizing power and assay compatibility at low percentages (≤0.5–1% v/v in final wells).
Secondary solvents for pre-dissolution if needed: DMF, acetonitrile, or methanol. For aqueous work, dilute DMSO stocks into buffer with vigorous mixing; consider the use of 0.01–0.05% non-ionic surfactant (e.g., Tween 20) to limit precipitation where compatible.
Aqueous buffers: Direct dissolution in water/PBS is often limited for hydrophobic compounds; evaluate empirically.
Decision points:
If compound is aromatic and hydrophobic (typical of many screening hits), prefer DMSO or DMF. If polar functionality is present (verify structure), methanol or acetonitrile may suffice.
For biophysical assays (SPR/ITC), minimize DMSO mismatch between sample and reference; prepare matched buffer with 1–2% DMSO if required.
Comparison (general):
DMSO: high solvency, low volatility; potential to affect enzyme activity at >1–2%.
DMF: strong solvency; higher toxicity and hygroscopic; limit in biological assays.
MeOH/ACN: volatile, easier removal; lower solubility window for hydrophobic scaffolds.
Practical tip:
Perform a 1 mg small-scale solubility test across candidate solvents at room temperature and 37°C; document maximum achievable concentration before precipitation upon aqueous dilution.
Storage and Reconstitution
Storage conditions (item-specific from Product Data):
Protected from light
Store at −20°C
Shipped in an ice chest with ice pads to maintain a low temperature during transit.
Reconstitution (general guidance for small molecules; verify compatibility experimentally):
Solvent: Use anhydrous DMSO for primary stock solutions unless your CoA/Spec Sheet indicates otherwise.
Concentration: Common stock levels are 10–50 mM for convenience in biochemical and cell-based assays. Adjust based on solubility and assay requirements.
Technique: Allow vial to warm to room temperature in the dark before opening to prevent condensation. Add calculated DMSO volume, then vortex and, if needed, sonicate briefly. If undissolved solids persist, gentle warming (≤40°C) may help; avoid prolonged heating or light exposure.
Aliquoting: Prepare single-use aliquots in amber or foil-wrapped microtubes to minimize freeze–thaw cycles and light exposure.
Stability and handling:
Working solutions in aqueous media are typically prepared fresh. If short-term storage is necessary, keep at 2–8°C protected from light and verify stability by LC–UV/LC–MS.
Record preparation date, solvent, and concentration on each aliquot. Discard upon visible precipitation, color change, or detection of degradation by analytical methods.
Note: Where specific solubility, stability, or purity data are required, consult the batch CoA/Spec Sheet.
Structure and Identity
Brief overview: LH846 is listed as a small-molecule screening compound; detailed structural identifiers are largely not provided in the item record.
Product name: LH846 (catalog SKU: L304252)
CAS: 639052-78-1
PubChem CID: 851474 (literature identifier)
InChIKey: 75983 (as provided; note: this appears truncated/non-standard; consult CoA/SDS or authoritative databases)
SMILES: Not specified for this item; refer to CoA/Spec Sheet.
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
Structural features (general note):
Item-specific functional groups, ring systems, and stereochemistry are not available in the provided Product Data. If your work requires a defined structural description (e.g., for docking, SAR, or cheminformatics), please retrieve the structure from the CoA/Spec Sheet or the cited external identifier (PubChem CID 851474) and verify against the batch-specific documentation.
2D description (how to read it, general guidance):
When available, interpret the 2D structure by enumerating aromatic vs. aliphatic rings, heteroatoms (N/O/S/halogens), H-bond donors/acceptors, and any chiral centers. These features guide solubility expectations (e.g., DMSO vs aqueous), potential metabolic liabilities, and assay compatibility.
Synthetic Utility
This product is offered as a defined small-molecule research compound; it is not primarily positioned as a synthetic reagent or building block in this catalog entry. Without a disclosed structure, detailed retrosynthetic commentary cannot be provided for this specific item.
General guidance (if derivatization/SAR is of interest):
After confirming the disclosed structure (e.g., via PubChem CID 851474 and verifying against CoA), identify synthetically addressable positions for analog generation (e.g., para-substitution on aryl rings, amide N-alkylation, heteroaryl swaps). Plan convergent routes that decouple core formation from late-stage diversification.
Protecting-group strategy should consider any phenols (e.g., silyl or benzyl ethers) or anilines (e.g., Boc/CBz), if present in the scaffold. Choose coupling chemistry (e.g., HATU/EDC for amide formation; Buchwald–Hartwig or Suzuki–Miyaura for aryl–N/C–C bond construction) according to functional group tolerance.
For rapid parallel synthesis, employ modern cross-coupling toolkits with precatalysts (e.g., Pd-PEPPSI, XPhos-type ligands) and robust bases/solvents (K3PO4 in dioxane/water; Cs2CO3 in toluene/EtOH/H2O), subject to the scaffold’s stability.
Analytical control:
Use LC–MS to track reactions; confirm purity by HPLC and identity by NMR (1H/13C, HSQC/HMBC as needed). Where polymorphism impacts bioassay reproducibility, perform PXRD/DSC characterization.
Target Specificity
This section is typically applicable to biological macromolecules (e.g., antibodies, recombinant proteins). LH846 is a small-molecule research compound; item-specific target selectivity data are not provided in the Product Data.
Literature context (to be verified independently):
Reports have associated LH846 with modulation of casein kinase 1 (CK1) activity in the context of Wnt/β-catenin signaling. If using for target-based studies, determine selectivity versus CK1 isoforms and broader kinome panels to assess off-target interactions.
Recommendation:
Generate or obtain a selectivity profile (e.g., Kd or IC50 across a kinase panel), evaluate time-dependence and ATP-competitiveness where applicable, and cross-validate in orthogonal assays (biochemical vs cellular). Document the exact structure and batch to ensure data traceability.
Häufig gestellte Fragen
What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at ?20 °C, protected from light. The material is light-sensitive — keep it in its original opaque or amber container.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 639052-78-1, the molecular formula is C16H13ClN2OS, and the molecular weight is 316.8 g/mol. InChIKey DYHAMRNAHTWYKY-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Wir verwenden Cookies, um die ordnungsgemäße Funktion der Website sicherzustellen und, soweit zulässig, Ihr Nutzererlebnis zu verbessern. Sie können Ihre Einstellungen jederzeit unter „Einstellungen“ verwalten. Weitere Informationen finden Sie in unserer Cookie-Richtlinie.
Dürfen wir Sie über Rabattaktionen informieren?
Später erinnern
Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.